Bath & Body Works, Inc. $BBWI Shares Sold by Bronte Capital Management Pty Ltd.

Bronte Capital Management Pty Ltd. lessened its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 38.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 155,508 shares of the company’s stock after selling 99,103 shares during the quarter. Bronte Capital Management Pty Ltd.’s holdings in Bath & Body Works were worth $2,903,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Global Retirement Partners LLC purchased a new stake in Bath & Body Works during the 4th quarter worth about $31,000. Activest Wealth Management purchased a new position in shares of Bath & Body Works in the 4th quarter valued at about $32,000. Geneos Wealth Management Inc. raised its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares in the last quarter. Parallel Advisors LLC raised its position in shares of Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares in the last quarter. Finally, Danske Bank A S purchased a new stake in Bath & Body Works during the third quarter worth approximately $39,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Weiss Ratings downgraded Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, June 2nd. Barclays cut their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a report on Thursday, May 28th. Telsey Advisory Group reduced their price objective on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a research report on Thursday, May 28th. UBS Group lowered their target price on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, May 20th. Finally, Piper Sandler assumed coverage on shares of Bath & Body Works in a research report on Friday, May 15th. They issued a “neutral” rating and a $20.00 target price on the stock. Three research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $22.00.

Bath & Body Works Stock Performance

BBWI opened at $21.95 on Friday. Bath & Body Works, Inc. has a one year low of $14.27 and a one year high of $33.96. The stock has a market capitalization of $4.42 billion, a P/E ratio of 6.17, a price-to-earnings-growth ratio of 2.22 and a beta of 1.38. The business’s 50-day simple moving average is $19.39 and its 200-day simple moving average is $20.37.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business’s revenue was down 3.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 2.62 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.6%. The ex-dividend date of this dividend was Friday, June 5th. Bath & Body Works’s dividend payout ratio is presently 22.47%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.